Valuation: Yuhan Corporation

Capitalization 7,823B 5.34B 4.55B 4.22B 3.96B 7.37B 489B 7.82B 48.21B 19.1B 231B 20.03B 19.62B 846B P/E ratio 2025 *
63.5x
P/E ratio 2026 * 47x
Enterprise value 7.73B 5.28M 4.49M 4.17M 3.91M 7.28M 483M 7.72M 47.63M 18.88M 228M 19.79M 19.39M 836M EV / Sales 2025 *
3.46x
EV / Sales 2026 * 3.15x
Free-Float
67.64%
Yield 2025 *
0.47%
Yield 2026 * 0.48%
More valuation ratios * Estimated data
Dynamic Chart
1 day+1.95%
1 week-3.14%
Current month-6.76%
1 month-9.66%
3 months-11.49%
6 months-16.16%
Current year-6.76%
More quotes
1 week 101,500
Extreme 101500
108,600
1 month 101,500
Extreme 101500
116,300
Current year 101,500
Extreme 101500
115,900
1 year 100,400
Extreme 100400
140,700
3 years 47,571.43
Extreme 47571.4286
166,900
5 years 47,571.43
Extreme 47571.4286
166,900
10 years 24,550.49
Extreme 24550.4865
166,900
More quotes
Manager TitleAgeSince
Chief Executive Officer 71 18/03/2021
Director of Finance/CFO 58 -
President 67 14/03/2024
Director TitleAgeSince
Chairman 74 18/03/2021
Director/Board Member 71 19/03/2015
Director/Board Member 61 29/02/2020
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+1.95%-3.14%-19.01%+106.07% 5.34B
-1.13%-2.50%-12.22%-34.22% 65.59B
+1.59%+3.16%+15.53%-7.93% 8.62B
-0.59%-0.74%+28.96%+38.53% 8.38B
+1.93%-2.84%+6.80%+62.06% 6.21B
+1.70%+1.99%+177.65%+36.90% 4.19B
-2.23%-4.89%-16.82%-22.35% 2.88B
-5.27%+1.99%+56.43%+43.35% 2.77B
-0.85%-2.31%+28.64%+21.81% 2.82B
Average -0.32%-1.12%+29.55%+27.14% 11.87B
Weighted average by Cap. -0.55%-0.59%+4.20%-7.17%
See all sector performances

Financials

2025 *2026 *
Net sales 2,232B 1.52B 1.3B 1.2B 1.13B 2.1B 140B 2.23B 13.75B 5.45B 65.94B 5.72B 5.6B 241B 2,424B 1.66B 1.41B 1.31B 1.23B 2.28B 152B 2.42B 14.94B 5.92B 71.61B 6.21B 6.08B 262B
Net income 133B 91.04M 77.49M 71.96M 67.47M 126M 8.34B 133M 822M 326M 3.94B 341M 334M 14.41B 173B 118M 100M 93.27M 87.44M 163M 10.81B 173M 1.06B 422M 5.11B 442M 433M 18.68B
Net Debt -93.49B -63.84M -54.33M -50.46M -47.31M -88.1M -5.85B -93.4M -576M -228M -2.76B -239M -234M -10.11B -199B -136M -116M -108M -101M -188M -12.47B -199M -1.23B -487M -5.89B -511M -500M -21.56B
More financial data * Estimated data
Logo Yuhan Corporation
Yuhan Corp is a Korea-based company mainly engaged in the manufacture and sale of pharmaceuticals. The Company operates its business through three segments. The Pharmaceutical segment is engaged in the production and sale of non-prescription drugs including anti-inflammatory drugs, as well as prescription drugs such as drugs for hepatitis, diabetes, and hypertension. The Life and Health segment is involved in the production and sale of household goods and animal healthcare (AHC) products, including bleach, antibacterial agents. The Overseas Business segment supplies raw drugs to domestic and overseas markets. The Company also sells licenses. The Company distributes its products in domestic and overseas markets such as Europe, Asia and United States.
Employees
2,067
More about the company
Date Price Change Volume
22/01/26 104,800.00 +1.95% 477,448
21/01/26 102,800.00 -4.28% 649,155
20/01/26 107,400.00 +1.42% 440,044
19/01/26 105,900.00 -1.85% 511,849
16/01/26 107,900.00 -0.28% 442,665

End-of-day quote Korea S.E., January 21, 2026

More quotes
Trader
Investor
Global
Quality
ESG MSCI
AA
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
104,800.00KRW
Average target price
148,555.56KRW
Spread / Average Target
+41.75%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. A000100 Stock